Sukhatme Mayukh
- SEC CIK
- 0001750050
Latest role at each company
- ROIV Roivant Sciences Ltd.President & CIOas of Aug 21, 2026
Trades
Every Form 4 that lists Sukhatme Mayukh as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| ROIVRoivant Sciences Ltd. | Aug 21, 20269:00 PM ET | Aug 19 – Aug 21, 2026 | Sukhatme MayukhPresident & CIO | SSaleCommon Shares | −335.17K | $36.8788 | −$12.36M | 18.63M | −1.8% | SEC |
| ROIVRoivant Sciences Ltd. | Aug 18, 20269:00 PM ET | Aug 14 – Aug 18, 2026 | Sukhatme MayukhPresident & CIO | SSaleCommon Shares | −664.83K | $36.3409 | −$24.16M | 18.63M | −3.4% | SEC |
| ROIVRoivant Sciences Ltd. | Jun 29, 2026 | Jun 25 – Jun 26, 2026 | Sukhatme MayukhPresident & CIO | SSaleCommon Shares | −1M | $34.105 | −$34.11M | 18.68M | −5.1% | SEC |
| ROIVRoivant Sciences Ltd. | Feb 11, 2026 | Feb 9, 2026 | Sukhatme MayukhPresident & CIO | SSaleCommon Shares | −339.44K | $26.47 | −$8.99M | 19.15M | −1.7% | SEC |
| ROIVRoivant Sciences Ltd. | Dec 31, 2025 | Dec 29 – Dec 31, 2025 | Sukhatme MayukhPresident & CIO | SSaleCommon Shares | −1.33M | $21.717 | −$28.9M | 20.27M | −6.2% | SEC |
| ROIVRoivant Sciences Ltd. | Dec 19, 2025 | Dec 17, 2025 | Sukhatme MayukhPresident & CIO | SSaleCommon Shares | −26.83K | $23.09 | −$619.53K | 18.87M | −0.1% | SEC |
| ROIVRoivant Sciences Ltd. | Dec 26, 2024 | Dec 23 – Dec 26, 2024 | Sukhatme MayukhPres&Chief Investment Officer | SSaleCommon Shares | −886.24K | $12.0078 | −$10.64M | 18.84M | −4.5% | SEC |
| ROIVRoivant Sciences Ltd. | Dec 20, 2024 | Dec 18, 2024 | Sukhatme MayukhPres&Chief Investment Officer | SSaleCommon Shares | −412.58K | $12.05 | −$4.97M | 18.84M | −2.1% | SEC |